592 results on '"Del Re, Marzia"'
Search Results
2. IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients
3. Targeting HER2 in breast cancer with brain metastases: A pharmacological point of view with special focus on the permeability of blood-brain barrier to targeted treatments
4. Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes
5. Clinical, Diagnostic and Therapeutic Framework of mHSPC and nmCRPC: A Multidisciplinary Consensus Project of the Italian Society for Uro-Oncology (SIUrO)
6. Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
7. Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
8. Facing an un-met need in lung cancer screening: The never smokers
9. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
10. ALK Inhibitors in Patients With ALK Fusion–Positive GI Cancers: An International Data Set and a Molecular Case Series
11. Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer
12. Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
13. Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma
14. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer
15. Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data
16. Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC
17. Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment
18. Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project
19. nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives
20. Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
21. Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
22. EGFR signaling pathway as therapeutic target in human cancers
23. Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival
24. The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
25. Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
26. The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies
27. The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
28. Precision Medicine in Oncology: Glossary of Relevant Scientific Terms
29. The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies
30. Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer
31. Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
32. PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients
33. Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors
34. A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
35. Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low‐grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis?
36. KRAS inhibition in non–small cell lung cancer: Past failures, new findings and upcoming challenges
37. Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA
38. Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs
39. TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
40. Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review
41. Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial
42. Changing the way we treat KRAS G12C non-small cell lung cancers
43. Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel
44. Understanding EGFR heterogeneity in lung cancer
45. erbB in NSCLC as a molecular target: current evidences and future directions
46. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
47. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
48. Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers
49. From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC
50. Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.